CME vs NDAQ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 13, 2026

CME

58.9
AI Score
VS
NDAQ Wins

NDAQ

60.1
AI Score

Investment Advisor Scores

CME

59score
Recommendation
HOLD

NDAQ

60score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CME NDAQ Winner
Forward P/E 22.9885 24.6914 CME
PEG Ratio 4.7612 2.3082 NDAQ
Revenue Growth 14.4% 13.7% CME
Earnings Growth 21.3% 33.8% NDAQ
Tradestie Score 58.9/100 60.1/100 NDAQ
Profit Margin 63.3% 35.3% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY NDAQ

Frequently Asked Questions

Based on our detailed analysis, NDAQ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.